FDA Inspection 674866 — Carl P. Griffin, M.D.
The FDA completed an inspection of Carl P. Griffin, M.D. on July 12, 2010 in Oklahoma City, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 12, 2010
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Oklahoma City, OK (United States)
Additional Details
Clinical Investigator (CI)